NMEs
Fitch to pharma: don’t expect 2012 to be a bumper year
July 31, 2012Sales and Marketing 2012, FDA approvals, Fitch, IMS Health, NMEs, ratings
The Fitch ratings agency has published pessimistic projections for pharma, saying that it should not expect as many US drug …
Latest content
The evidence bar impacting UK medical cannabis access
November 6, 2026
Addressing the rheumatic disease diagnostic gap in primary care
November 5, 2026
